JPS5932142B2 - Hollow fiber membrane type blood processing device - Google Patents
Hollow fiber membrane type blood processing deviceInfo
- Publication number
- JPS5932142B2 JPS5932142B2 JP16262680A JP16262680A JPS5932142B2 JP S5932142 B2 JPS5932142 B2 JP S5932142B2 JP 16262680 A JP16262680 A JP 16262680A JP 16262680 A JP16262680 A JP 16262680A JP S5932142 B2 JPS5932142 B2 JP S5932142B2
- Authority
- JP
- Japan
- Prior art keywords
- hollow fiber
- fiber membrane
- blood
- membrane
- processing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000012528 membrane Substances 0.000 title claims description 84
- 239000012510 hollow fiber Substances 0.000 title claims description 80
- 210000004369 blood Anatomy 0.000 title claims description 54
- 239000008280 blood Substances 0.000 title claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000005192 partition Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229920002239 polyacrylonitrile Polymers 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- -1 ester compounds Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002615 hemofiltration Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- DOKHEARVIDLSFF-UHFFFAOYSA-N prop-1-en-1-ol Chemical compound CC=CO DOKHEARVIDLSFF-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
【発明の詳細な説明】
本発明は半透膜あるいは多孔膜を使用し、この壁膜を通
じて浸透、透析、限外濾過及びガス拡散等の原理を利用
して血液中の物質を移動させるように構成した血液処理
装置、特に該膜が中空糸状をなしたものを使用する改良
された中空糸膜束を有する血液処理装置に関するもので
ある。DETAILED DESCRIPTION OF THE INVENTION The present invention uses a semipermeable membrane or a porous membrane, and uses principles such as osmosis, dialysis, ultrafiltration, and gas diffusion to move substances in the blood. The present invention relates to a blood processing device having an improved hollow fiber membrane bundle, in particular to a blood processing device having an improved hollow fiber membrane bundle in which the membranes are in the form of hollow fibers.
従来この種の血液処理装置は、腎不全患者、薬物中毒患
者等の血液から有害物を除去して血液の浄化を行なうた
めの人工腎臓装置及び人工肝臓装置や酸素と炭酸ガスと
を交換する人工肺装置等として広く使用されている。Conventionally, this type of blood processing equipment has been used to purify the blood by removing harmful substances from the blood of patients with renal failure, drug addiction, etc., as well as artificial liver equipment and artificial liver equipment that exchange oxygen and carbon dioxide gas. Widely used as lung devices, etc.
本発明はこれらの血液処理装置に使用される改良された
装置を提供するものである。The present invention provides an improved device for use in these blood processing devices.
このような血液処理装置は一般に多数の中空糸膜を束に
し、その両端の切断面を外部から密閉した空間に面せし
め、その一方の空間へ処理すべき流体、例えば血液を導
入し、中空糸膜内部を通り抜けた流体を他端の切断面か
らもう一方の空間に集め、外部排出管へ排出するような
構成をとるものが多い。Such blood processing equipment generally bundles a large number of hollow fiber membranes, makes the cut surfaces of both ends face a closed space from the outside, introduces the fluid to be treated, such as blood, into one of the spaces, and then Many membrane membranes have a configuration in which the fluid that has passed through the membrane is collected in the other space from the cut surface at the other end and is discharged to an external discharge pipe.
通常この空間を形成するためヘッダーと称すものが設け
られている。Usually, something called a header is provided to form this space.
中空糸膜の束は円形もしくは偏平型に形成されることが
多い。A bundle of hollow fiber membranes is often formed in a circular or flat shape.
円形に中空糸膜が束ねられたいわゆる円筒タイプの縦来
型血液透析器を例にとり、この種の血液処理装置の例を
示すと第1図のようになる。An example of this type of blood processing apparatus is shown in FIG. 1, taking as an example a so-called cylindrical type vertical hemodialyzer in which hollow fiber membranes are bundled in a circular shape.
第1図中、1は血液を中空糸膜5の内部空間に導くよう
に、かつ外部と隔離する為に設けられた断面が円形の入
口側ヘッダーであり血液10は導入口20より導入され
る。In FIG. 1, reference numeral 1 denotes an inlet header with a circular cross section, which is provided to guide blood into the internal space of the hollow fiber membrane 5 and to isolate it from the outside. Blood 10 is introduced from an inlet 20. .
1aは中空糸膜の内部空間を通過してきた血液を集合さ
せ一定の大きさの管に排出口20aより排出するように
、かつ外部と隔離する為に設けられた断面が円形の出口
側ヘッダーである。1a is an exit side header with a circular cross section that is provided to collect the blood that has passed through the internal space of the hollow fiber membrane and discharge it from the outlet 20a into a tube of a certain size, and to isolate it from the outside. be.
2はヘッダー1又は1aが外筒3と分離しないように、
また、ヘッダー内に導ひかれた血液が外部に洩れずに中
空糸膜5の内部空間に導ひく為にヘッダー1又は1aを
パツキン12を介して中空糸膜群を固定する隔壁6に密
着させる為に設けられた固定キャップである。2 so that the header 1 or 1a does not separate from the outer cylinder 3,
In addition, in order to guide the blood drawn into the header into the internal space of the hollow fiber membrane 5 without leaking to the outside, the header 1 or 1a is brought into close contact with the partition wall 6 that fixes the hollow fiber membrane group through the packing 12. It is a fixed cap provided on the
外筒3は好ましくは円筒形であってその内部が目視でき
るように透明で硬質の合成樹脂で作られ、その内部空間
9には数百乃至−万本程度の中空糸膜5が充填されてい
る。The outer cylinder 3 is preferably cylindrical and made of a transparent, hard synthetic resin so that its interior can be seen visually, and its internal space 9 is filled with several hundred to ten thousand hollow fiber membranes 5. There is.
又この外筒3には、透析液の導入口4及び排出口4aが
設けられている。Further, this outer cylinder 3 is provided with an inlet 4 and an outlet 4a for dialysate.
中空糸膜5は、外筒3の内部空間9に多数充填され、そ
の両端は血液適合性に優れた隔壁6で液密に固定され、
しかも中空糸膜5の内部空間はヘッダーの内部空間8と
連通している。A large number of hollow fiber membranes 5 are filled in the internal space 9 of the outer cylinder 3, and both ends thereof are fixed in a fluid-tight manner by partition walls 6 having excellent blood compatibility.
Moreover, the internal space of the hollow fiber membrane 5 communicates with the internal space 8 of the header.
又隔壁6は一般にポリウレタン樹脂が使用されているが
この隔壁6によってヘッダーの内部空間8は、外筒3の
内部空間9と隔離され、ヘッダーの内部空間8及び外筒
3の内部空間9は中空糸膜5の壁膜を介してのみ接触す
るようになっている。Furthermore, the partition wall 6 is generally made of polyurethane resin, and the partition wall 6 separates the internal space 8 of the header from the internal space 9 of the outer cylinder 3, and the internal space 8 of the header and the internal space 9 of the external cylinder 3 are hollow. Contact is made only through the wall membrane of the thread membrane 5.
すなわち導入される血液10はヘッダー内空間8を経由
して中空糸膜の内部空間に入り、中空糸膜の壁膜を介し
て血液中の有害物を外筒3の内部空間9に排出し、清浄
になった血液は出口側ヘッダー1aの内部空間を経由し
て体内にもどされ、逆に外筒3の内部空間9に排出され
た有害物は導入管4より導入された透析液11によって
運ばれ排出管4aを経由して外部へ取り出される。That is, the introduced blood 10 enters the internal space of the hollow fiber membrane via the header internal space 8, and harmful substances in the blood are discharged into the internal space 9 of the outer cylinder 3 through the wall membrane of the hollow fiber membrane. The purified blood is returned to the body via the internal space of the outlet header 1a, and the harmful substances discharged into the internal space 9 of the outer cylinder 3 are transported by the dialysate 11 introduced from the inlet tube 4. The debris is taken out to the outside via the discharge pipe 4a.
しかしながら、このような従来の円筒タイプの血液処理
装置は次のような問題がある。However, such conventional cylindrical blood processing apparatuses have the following problems.
すなわち第1図において、中空糸膜5の切断面7より内
部に流入する血液は、その切断面の大きさの不均一性、
入口側ヘッダーの血液導入口20より導入する血液が有
する動圧分布等により必らずしも均一にならない。That is, in FIG. 1, blood flowing into the interior from the cut surface 7 of the hollow fiber membrane 5 is caused by non-uniformity in the size of the cut surface,
The blood introduced from the blood introduction port 20 of the inlet side header does not necessarily become uniform due to the dynamic pressure distribution of the blood.
特に切断面中央部表面にかかる血液の動圧は周囲より大
きいので、中央部の中空糸膜の方が周囲の中空糸膜より
流人血液量は大きくなる。In particular, since the dynamic pressure of blood applied to the surface of the central part of the cut surface is greater than that of the surrounding area, the amount of blood flowing through the central hollow fiber membrane is larger than that of the surrounding hollow fiber membrane.
このように多数の中空糸膜相互間に血液流量の不均一が
生ずる場合は、血液透析装置又は血液濾過装置全体とし
ては、透析性能又は限外濾過量が低下すると共に、血液
透析又は血液瀘過後返血する際に返血速度が異なる為に
、外周部にある中空糸膜群の内部空間に残血という現象
を引き起こす。If non-uniform blood flow occurs between a large number of hollow fiber membranes, the dialysis performance or ultrafiltration rate of the hemodialysis device or hemofiltration device as a whole will decrease, and the When blood is returned, the blood return speed is different, which causes a phenomenon of blood remaining in the internal space of the hollow fiber membrane group at the outer periphery.
特に長時間の血液透析や長時間の血液E過を行なう場合
、血液量の少ない中空糸膜の内部空間では凝血を引き起
こし、血液の流れが停止する部分も生じる。Particularly when long-term hemodialysis or long-term blood E-filtration is performed, blood clots occur in the internal space of the hollow fiber membrane where the amount of blood is small, and there are parts where blood flow stops.
本発明はかかる事情に鑑みてなされたものであって、そ
の目的とするところは、ヘッダー内に導入された血液が
全中空糸膜の内部空間に容易に導入される事及び中空糸
膜の切断面に於ける溶血(赤血球の破壊)並びに該切断
面付近に生じる凝血を解消する事である。The present invention has been made in view of the above circumstances, and its objects are to easily introduce the blood introduced into the header into the internal space of all the hollow fiber membranes, and to cut the hollow fiber membranes. The goal is to eliminate hemolysis (destruction of red blood cells) at the surface and blood clots that occur near the cut surface.
本発明は固定された中空糸膜の切断面における中空糸膜
の内径を、例えばラッパ状に拡大することによって、長
時間の血液透析や血液濾過が可能となるようにした事を
特徴とする中空糸膜の血液処理装置である。The present invention is characterized in that the inner diameter of the hollow fiber membrane at the cut surface of the fixed hollow fiber membrane is expanded, for example, into a trumpet shape, thereby enabling long-term hemodialysis and hemofiltration. This is a thread membrane blood processing device.
本発明の対象となる中空糸は、キュプラアンモニウムレ
ーヨン、ザンテートレーヨン、セルロースアセテートお
よびニトロセルロース等のセルロース系繊維の中空糸、
ポリビニルアルコール系中空繊維、ポリメチルメタクリ
レート系中空繊維、ポリ塩化ビニル中空繊維、ポリアク
リロニトリル系中空繊維、ポリスルホン中空繊維、ポリ
ペプチド中空繊維、コラーゲン中空繊維、ポリカーボネ
ート中空繊維等の多孔性合成高分子の中空糸膜である。Hollow fibers targeted by the present invention include hollow fibers of cellulose fibers such as cuproammonium rayon, xantate rayon, cellulose acetate, and nitrocellulose;
Hollow holes in porous synthetic polymers such as polyvinyl alcohol hollow fibers, polymethyl methacrylate hollow fibers, polyvinyl chloride hollow fibers, polyacrylonitrile hollow fibers, polysulfone hollow fibers, polypeptide hollow fibers, collagen hollow fibers, and polycarbonate hollow fibers. It is a thread membrane.
又これらの中空糸膜の切断面を拡大する方法は、当該中
空糸膜の性質により異なるが、一般的には、当該中空糸
膜を固定し、切断面を表面に出した後、中空糸膜の先端
部を各中空糸材質にあった極性膨潤剤に浸漬し、中空糸
膜の先端部が膨潤したのを確認後、該膨潤剤より取り出
し、熱源で乾燥して該膨潤剤を取り除くと同時に、該中
空糸膜の壁厚を外側へ収縮させることによって中空糸膜
の構造を、ラッパ状に内径を拡大することができる。The method for enlarging the cut surface of these hollow fiber membranes varies depending on the properties of the hollow fiber membrane, but generally, after fixing the hollow fiber membrane and exposing the cut surface, the hollow fiber membrane is expanded. The tip of the hollow fiber membrane is immersed in a polar swelling agent suitable for each hollow fiber material, and after confirming that the tip of the hollow fiber membrane has swelled, it is removed from the swelling agent and dried with a heat source to remove the swelling agent. By contracting the wall thickness of the hollow fiber membrane outward, the inner diameter of the hollow fiber membrane structure can be expanded into a trumpet shape.
又別法としては、直接熱源のみで中空糸膜の壁厚を外側
へ収縮させ、内径を拡大させる場合もある。Alternatively, the inner diameter may be expanded by shrinking the wall thickness of the hollow fiber membrane outward using only a direct heat source.
使用する極性膨潤剤としては、水、アルコール類、ケト
ン類、アミン類、エーテル類、エステル化合物、ジメチ
ルスルホキシド、ジメチルホルムアミド等色々考えられ
るが、操作上簡便な物質としては、水およびメタノール
、エタノール、プロペノール、イソプロピルアルコール
等の低沸点アルコール、アセトン、メチルエチルケトン
等のケトン化合物、メチルエーテル、エチルエーテル等
のエーテル化合物等が最適である。Various polar swelling agents can be used, such as water, alcohols, ketones, amines, ethers, ester compounds, dimethyl sulfoxide, dimethyl formamide, etc. However, substances that are easy to use include water, methanol, ethanol, Low boiling point alcohols such as propenol and isopropyl alcohol, ketone compounds such as acetone and methyl ethyl ketone, and ether compounds such as methyl ether and ethyl ether are most suitable.
本発明におけるこのような方法は多孔性の高分子の中空
糸膜や収縮性のある物質の中空糸膜について用いること
が可能である。Such a method in the present invention can be used for hollow fiber membranes of porous polymers or hollow fiber membranes of shrinkable materials.
特に本発明の処理方法で中空糸膜を処理すると中空糸膜
の収縮度の程度にもよるが当該中空糸膜の壁厚をそのま
まの状態より約1/1o程度迄の範囲で収縮させる事が
できる。In particular, when a hollow fiber membrane is treated with the treatment method of the present invention, the wall thickness of the hollow fiber membrane can be reduced to about 1/10 of that in its original state, although it depends on the degree of shrinkage of the hollow fiber membrane. can.
以下図面によって本発明をより詳細に説明する。The present invention will be explained in more detail below with reference to the drawings.
第2図は第1図の入口側ヘッダ一部分のみを拡大して示
した図である。FIG. 2 is an enlarged view of only a portion of the entrance side header of FIG. 1.
中空糸膜束の切断面が見易いようになっている。The cut surface of the hollow fiber membrane bundle is easy to see.
第3図は第2図における中空糸膜の切断面を本発明のご
とく、内径拡大したものを例示しである。FIG. 3 shows an example of a cross section of the hollow fiber membrane shown in FIG. 2 with the inner diameter enlarged as in the present invention.
この図の場合、内径はその切断面に向かうテーパー状と
なっている。In this figure, the inner diameter tapers toward the cut surface.
このように本発明の血液処理装置は、その中空糸膜の切
断面において内径が拡大されているので、導入される血
液に対する端部での抵抗が小となり、流れの乱れを生じ
ることも少なく、スムーズに流入するので、血液の中空
糸膜内部への流入量の不均一性も改善される。As described above, in the blood processing device of the present invention, since the inner diameter is enlarged at the cut surface of the hollow fiber membrane, the resistance to the introduced blood at the end is small, and the flow is less likely to be disturbed. Since blood flows smoothly, non-uniformity in the amount of blood flowing into the hollow fiber membrane is also improved.
次に実施例により、中空糸膜の切断面における中空糸膜
の孔径を拡大する方法と当該処理を施した中空糸膜を充
填した血液処理装置と従来型の血液処理装置との性能の
比較を示す。Next, in an example, we will compare the method of enlarging the pore diameter of the hollow fiber membrane at the cut surface of the hollow fiber membrane and the performance of a blood processing device filled with a hollow fiber membrane subjected to this treatment and a conventional blood processing device. show.
実施例 1
内径300μ、膜厚50μのポリアクリロニトリル中空
糸膜2200本を外筒3に隔壁6で固定し、両端を切断
して中空糸膜の切断面が外部表面に出てくるようにした
ものについて、その一方の端部を約5m適度、用意した
水に浸漬し、数分後水中より取り出し、その後当該中空
糸膜を固定した外筒3を振って大部分の水を飛ばし、そ
の切断面を約80℃の熱風で乾燥させる事によって、中
空糸膜の切断面に於ける内径を拡大させ、切断面内径3
80μの孔径の中空糸膜を得た。Example 1 2200 polyacrylonitrile hollow fiber membranes with an inner diameter of 300 μm and a membrane thickness of 50 μm were fixed to an outer cylinder 3 with a partition wall 6, and both ends were cut so that the cut surfaces of the hollow fiber membranes were exposed to the external surface. One end of the hollow fiber membrane was immersed in prepared water for about 5 m, and after a few minutes it was taken out of the water, and the outer cylinder 3 to which the hollow fiber membrane was fixed was shaken to remove most of the water, and the cut surface was By drying with hot air at about 80℃, the inner diameter at the cut surface of the hollow fiber membrane is expanded, and the inner diameter at the cut surface is 3.
A hollow fiber membrane with a pore size of 80μ was obtained.
又もう一方の端部についても、前述と同様の操作により
内径を拡大させた。The inner diameter of the other end was also enlarged by the same operation as described above.
実施例 2
実施例1に於いて使用した水の代りにエタノールを使用
した場合も、上述と同一の操作で中空糸膜の切断面に於
ける内径は375μに拡大された3実施例 3
内径250μ、膜厚30μのキュプラアンモニウムレー
ヨンの中空糸膜に於いて、実施例1と同じ操作を行なっ
た。Example 2 Even when ethanol was used instead of the water used in Example 1, the inner diameter at the cut surface of the hollow fiber membrane was expanded to 375μ by the same operation as described above.Example 3: The inner diameter was 250μ The same operation as in Example 1 was carried out using a cuproammonium rayon hollow fiber membrane having a membrane thickness of 30 μm.
中空糸膜の切断面に於ける内径は280μに拡大された
。The inner diameter of the hollow fiber membrane at the cut surface was expanded to 280μ.
実施例 4
実施例1で得た中空糸膜の血液処理装置(以下改良型と
略す)と従来型の血液処理装置(以下比較例と略す)の
それぞれの血液処理装置(内径300μのポリアクリロ
ニトリル中空糸膜使用、中空糸膜本数2200本、有効
膜面積0.23m、中空糸膜充填率50%)に生新鮮血
(ヘマトクリット値35%、全タンパク質濃度9.2,
9/d!’ )を膜差圧(Trans Membran
e Pressure ) 25mrn Hg s
装置出入口の差圧ΔPB=25mmHgのもとで導入し
、3時間後の血液通過量、限外濾過量及び返血後の残血
本数を測定した結果を表−1に示す。Example 4 The hollow fiber membrane blood processing device obtained in Example 1 (hereinafter abbreviated as improved type) and the conventional blood processing device (hereinafter abbreviated as comparative example) were tested (polyacrylonitrile hollow membrane with an inner diameter of 300 μm). Fiber membrane used, 2200 hollow fiber membranes, effective membrane area 0.23 m, hollow fiber membrane filling rate 50%) and fresh blood (hematocrit value 35%, total protein concentration 9.2,
9/d! ') to trans membrane differential pressure (Trans Membrane pressure)
e Pressure) 25 mrn Hg s
Table 1 shows the results of measuring the amount of blood passing through the device, the amount of ultrafiltration, and the number of blood remaining after blood return after 3 hours of introducing the device under a differential pressure ΔPB of 25 mmHg at the entrance and exit of the device.
表−1かられかるように本発明の血液処理装置では、血
液通過量、限外E過量は比較例と比べて3倍強の値を示
し、さらに残血本数にいたっては約1/1oに低減する
。As can be seen from Table 1, in the blood processing device of the present invention, the amount of blood passing through and the amount of excess E exceeded three times that of the comparative example, and the number of remaining blood was approximately 1/10. Reduce to
このように中空糸膜群の切断面に於いて中空糸膜の内径
を拡大する事によって装置の性能は一段と向上する。In this way, by enlarging the inner diameter of the hollow fiber membranes at the cut plane of the hollow fiber membrane group, the performance of the device is further improved.
従って本発明の血液処理装置は、色々な血液処理装置に
充分効果を発揮すると共に、装着型人工腎臓等の血液ポ
ンプを使用しない場合には特にその効果を発揮するもの
である。Therefore, the blood processing device of the present invention is sufficiently effective for various blood processing devices, and is particularly effective when a blood pump such as a wearable artificial kidney is not used.
第1図は血液処理装置の全体図であり、第2図はそのヘ
ッダー及び中空糸膜群の切断面を拡大したもの。
第3図は本発明の中空糸膜群の切断面に於ける中空糸膜
の内径を拡大した時の図である。
図中1,1aは入口側ヘッダー及び出口側ヘッダー、3
は外筒、4,4aは透析液の導入又は排出の為のポート
、5は中空糸膜、7は中空糸膜群の切断面であり10,
10aは導入される血液と排出される血液を示す。Fig. 1 is an overall view of the blood processing device, and Fig. 2 is an enlarged cross-sectional view of the header and hollow fiber membrane group. FIG. 3 is an enlarged view of the inner diameter of the hollow fiber membranes at a cross section of the hollow fiber membrane group of the present invention. In the figure, 1 and 1a are the inlet side header and the outlet side header, 3
is an outer cylinder, 4 and 4a are ports for introducing or discharging dialysate, 5 is a hollow fiber membrane, 7 is a cut surface of the hollow fiber membrane group, and 10,
10a shows blood introduced and blood discharged.
Claims (1)
糸膜の内径が切断面においてのみ拡大されていることを
特徴とする中空糸膜型血液処理装置。1. A hollow fiber membrane type blood processing device using a hollow fiber membrane bundle, characterized in that the inner diameter of the hollow fiber membrane is enlarged only at the cut surface.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16262680A JPS5932142B2 (en) | 1980-11-20 | 1980-11-20 | Hollow fiber membrane type blood processing device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16262680A JPS5932142B2 (en) | 1980-11-20 | 1980-11-20 | Hollow fiber membrane type blood processing device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5786362A JPS5786362A (en) | 1982-05-29 |
| JPS5932142B2 true JPS5932142B2 (en) | 1984-08-07 |
Family
ID=15758179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16262680A Expired JPS5932142B2 (en) | 1980-11-20 | 1980-11-20 | Hollow fiber membrane type blood processing device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5932142B2 (en) |
-
1980
- 1980-11-20 JP JP16262680A patent/JPS5932142B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5786362A (en) | 1982-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100438933C (en) | Dialyser and its producing method | |
| US3505686A (en) | Device for effecting blood interchange functions | |
| JP2003520617A (en) | Potting a tubular bundle into the housing | |
| US20170000937A1 (en) | Dialysis Apparatus Comprising a Dialyzer | |
| US4231877A (en) | Blood dialyzer | |
| CS226188B2 (en) | Dialysing diaphragm in the form of flat foil,tubular foil or hollow filament made of cellulose regenerated by using cuoxam process | |
| EP1658126B1 (en) | Surface treatment of the membrane and associated product | |
| JP3297707B2 (en) | Modified hollow fiber and method for producing the same | |
| JPS5932142B2 (en) | Hollow fiber membrane type blood processing device | |
| JPS6241738B2 (en) | ||
| JPH10263375A (en) | Permselective hollow fiber membrane | |
| JPH0548705B2 (en) | ||
| JPS605308B2 (en) | Blood processing device consisting of hollow fiber membrane bundle | |
| JPS6030224B2 (en) | Blood processing device with hollow fiber membrane bundle | |
| JP2961481B2 (en) | Hemodialyzer and hemofilter | |
| JP3295321B2 (en) | Permselective hollow fiber membrane | |
| JP2000042099A (en) | Hollow fiber membrane type blood dialyzer | |
| JP2005118506A (en) | On-line massive fluid replacement type hemodialyzer | |
| JP7224104B2 (en) | Dialysis device with improved internal filtration and method of manufacture | |
| JPS61268304A (en) | Fluid separator | |
| JP2005007004A (en) | Hollow fiber type body fluid treatment apparatus, hollow fiber bundle used therefor, and method for producing them | |
| JP3253885B2 (en) | Permselective hollow fiber membrane | |
| JPS609820B2 (en) | Hollow fiber membrane mass transfer device | |
| JP2002001073A (en) | Selective removal membrane and blood processor using the same | |
| JPS5875555A (en) | Blood treating apparatus |